Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2026-05-20 @ 5:42 AM
Study NCT ID:
NCT03275402
Status:
TERMINATED
Last Update Posted:
2024-02-13
First Post:
2017-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Sponsor:
Y-mAbs Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None